Literature DB >> 20144641

Loxoscelism: From basic research to the proposal of new therapies.

Denise V Tambourgi1, Rute M Gonçalves-de-Andrade, Carmen W van den Berg.   

Abstract

Loxoscelism is caused by envenomation by spiders from Loxosceles genus. Clinical symptoms only appear a few hours after envenomation and can evolve in local reactions, such as dermonecrosis, and systemic reactions, such as intravascular haemolysis, intravascular coagulation and renal failure. Current therapies are not effective, often not based in scientific research and can be even detrimental. A lack of understanding of the mechanism of action of the venom of the Loxosceles spider had thus far prevented development of effective therapies. In this review we aim to give an overview of our contributions to the understanding of the mechanism of action of the Loxosceles venom and propose targets and therapeutics for medical intervention.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20144641     DOI: 10.1016/j.toxicon.2010.01.021

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  29 in total

1.  Diethyl Azelate for the Treatment of Brown Recluse Spider Bite, a Neglected Orphan Indication.

Authors:  Robert T Streeper; Elzbieta Izbicka
Journal:  In Vivo       Date:  2022 Jan-Feb       Impact factor: 2.155

2.  Documented cutaneous loxoscelism in the south of France: an unrecognized condition causing delay in diagnosis.

Authors:  Emma Rubenstein; Pierre Emmanuel Stoebner; Christian Herlin; Catherine Lechiche; Christine Rollard; Didier Laureillard; Albert Sotto
Journal:  Infection       Date:  2016-01-07       Impact factor: 3.553

3.  Variable Substrate Preference among Phospholipase D Toxins from Sicariid Spiders.

Authors:  Daniel M Lajoie; Sue A Roberts; Pamela A Zobel-Thropp; Jared L Delahaye; Vahe Bandarian; Greta J Binford; Matthew H J Cordes
Journal:  J Biol Chem       Date:  2015-03-09       Impact factor: 5.157

4.  Secondary hemophagocytic lymphohistiocytosis (HLH) from a presumed brown recluse spider bite.

Authors:  Christopher Dandoy; Michael Grimley
Journal:  J Clin Immunol       Date:  2014-04-16       Impact factor: 8.317

Review 5.  Brown spider (Loxosceles genus) venom toxins: tools for biological purposes.

Authors:  Olga Meiri Chaim; Dilza Trevisan-Silva; Daniele Chaves-Moreira; Ana Carolina M Wille; Valéria Pereira Ferrer; Fernando Hitomi Matsubara; Oldemir Carlos Mangili; Rafael Bertoni da Silveira; Luiza Helena Gremski; Waldemiro Gremski; Andrea Senff-Ribeiro; Silvio Sanches Veiga
Journal:  Toxins (Basel)       Date:  2011-03-22       Impact factor: 4.546

6.  Sphingomyelinase D activity in model membranes: structural effects of in situ generation of ceramide-1-phosphate.

Authors:  Roberto P Stock; Jonathan Brewer; Kerstin Wagner; Blanca Ramos-Cerrillo; Lars Duelund; Kit Drescher Jernshøj; Lars Folke Olsen; Luis A Bagatolli
Journal:  PLoS One       Date:  2012-04-25       Impact factor: 3.240

7.  Phospholipase D toxins of brown spider venom convert lysophosphatidylcholine and sphingomyelin to cyclic phosphates.

Authors:  Daniel M Lajoie; Pamela A Zobel-Thropp; Vlad K Kumirov; Vahe Bandarian; Greta J Binford; Matthew H J Cordes
Journal:  PLoS One       Date:  2013-08-29       Impact factor: 3.240

8.  Venom of the Brazilian spider Sicarius ornatus (Araneae, Sicariidae) contains active sphingomyelinase D: potential for toxicity after envenomation.

Authors:  Priscila Hess Lopes; Rogério Bertani; Rute M Gonçalves-de-Andrade; Roberto H Nagahama; Carmen W van den Berg; Denise V Tambourgi
Journal:  PLoS Negl Trop Dis       Date:  2013-08-22

9.  Brown Recluse spider bite mediated hemolysis: clinical features, a possible role for complement inhibitor therapy, and reduced RBC surface glycophorin A as a potential biomarker of venom exposure.

Authors:  Eric A Gehrie; Hui Nian; Pampee P Young
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

10.  Tuning voltage-gated channel activity and cellular excitability with a sphingomyelinase.

Authors:  David J Combs; Hyeon-Gyu Shin; Yanping Xu; Yajamana Ramu; Zhe Lu
Journal:  J Gen Physiol       Date:  2013-09-16       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.